Addenbrooke's Hospital
Research and Development
The Rosie Hospital
Former Trust chairman's wife opens Deakin Centre named in his honour
The Deakin Centre was officially opened this week by Daphne Deakin - the wife of former Cambridge University Hospital's Trust chairman Tony who the centre is named in honour of.
Joint medicine for members lecture: 'A shady tale of con, swindle and deceit'
14 June 2012 - OCD (obsessive compulsive disorder) exposed by Dr Jan van Niekerk, Postdoctoral Research Fellow in Clinical Psychology
CUH and Papworth choose two world-class IT suppliers to transform patient services
Cambridge University Hospitals and Papworth Hospital have chosen Hewlett Packard (HP) and Epic to help them transform patient services through technology-supported business change.
New Regius Professor of Physic for University of Cambridge
Professor Patrick Maxwell will be one of CUH’s seven non-executive directors when he takes up his new appointment as Regius Professor of Physic at the University of Cambridge.
New role for Addenbrooke's chief executive
After nearly six years as chief executive, Dr Gareth Goodier will be leaving Cambridge University Hospitals in June 2012 having accepted a position in a major healthcare organisation in Australia.
New UK-led research has shown that starting treatment for high blood pressure with two medicines rather than the one produces better and faster results and fewer side effects.
Professor Morris Brown
Traditionally, doctors begin treatment with one medicine, adding others over time if necessary. The study showed that starting treatment with a combination of two medicines resulted in improved and faster control of blood pressure and fewer side effects. To simplify treatment for patients, both medicines can be incorporated into a single pill.
Prof Brown said: “The ACCELERATE study breaks the mould for treating hypertension. Most patients can now be prescribed a single combination pill and know that they are optimally protected from strokes and heart attacks.”
The study of 1,250 patients showed that those starting treatment with a single tablet containing a combination of drugs will have a 25% better response during the first six months than patients receiving conventional treatment. They also experience fewer side effects and are less likely to stop their treatment as a result.
In addition, ACCELERATE showed that patients who switch from a single drug treatment (monotherapy) to combination therapy will also benefit, but not to the same level as those who began with combination therapy.
Prof Bryan Williams, of the British Hypertension Society, said: “This study is important and the findings could change the way we approach the treatment of high blood pressure.”
Currently there are almost ten million people in the UK with hypertension. As well as being extremely cost effective, effective treatment to lower their blood pressure also substantially reduces the risk of stroke and heart disease.
Contact the PR and Communications team:
Cambridge University Hospitals NHS Foundation Trust,
Box 53, Hills Road,
Cambridge CB2 0QQ
Tel: 01223 245 151